Equillium, Inc.
EQ- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001746466
No open-market purchases or sales by Equillium, Inc. insiders were filed in the last 90 days; 60 institutions reported holding it in 13F filings for Q2 2026, worth $133.0M in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in Equillium, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 25
- −2 vs. Q2 2023
- Shares held
- 9.12M
- −799.1K (−8.1%) vs. Q2 2023
- Total value
- $6.75M
- −$690.2K (−9.3%) vs. Q2 2023
- New holders
- 1
- 6 more added
- Sold out
- 3
- 6 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting EQ on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 60 | $133.0M |
| Q1 2026 | 50 | $81.0M |
| Q4 2025 | 36 | $54.7M |
| Q3 2025 | 40 | $42.4M |
| Q2 2025 | 27 | $2.74M |
| Q1 2025 | 24 | $3.39M |
| Q4 2024 | 26 | $6.52M |
| Q3 2024 | 26 | $7.25M |
| Q2 2024 | 25 | $6.15M |
| Q1 2024 | 28 | $20.5M |
| Q4 2023 | 25 | $6.85M |
| Q3 2023 | 25 | $6.75M |
| Q2 2023 | 27 | $7.44M |
| Q1 2023 | 28 | $7.86M |
| Q4 2022 | 31 | $13.3M |
| Q3 2022 | 30 | $28.4M |
| Q2 2022 | 25 | $25.6M |
| Q1 2022 | 30 | $39.7M |
| Q4 2021 | 26 | $27.0M |
| Q3 2021 | 22 | $49.9M |
| Q2 2021 | 28 | $41.9M |
| Q1 2021 | 33 | $54.6M |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Equillium, Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 299 | $0 | 0.00% | −168−36.0% | Reduced |
| Group One Trading, L.P. | 200 | $148 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 1,139 | $843 | 0.00% | +3+0.3% | Added |
| Simplex Trading, LLC | 2,073 | $1.00K | 0.00% | +3+0.1% | Added |
| BlackRock Inc. | 9,826 | $7.27K | 0.00% | +102+1.0% | Added |
| Tower Research Capital LLC (TRC) | 9,892 | $7.32K | 0.00% | −2,627−21.0% | Reduced |
| Capital CS Group, LLC | 19,000 | $14.1K | 0.02% | 00.0% | Unchanged |
| Millennium Management LLC | 25,838 | $19.1K | 0.00% | −48,266−65.1% | Reduced |
| Northern Trust Corp | 35,155 | $26.0K | 0.00% | 00.0% | Unchanged |
| Two Sigma Securities, LLC | 36,287 | $26.9K | 0.00% | +36,287 | New |
| Integrated Wealth Concepts LLC | 40,000 | $29.6K | 0.00% | +8,661+27.6% | Added |
| Citadel Advisors LLC | 46,983 | $34.8K | 0.00% | +331+0.7% | Added |
| State Street Corp | 56,220 | $41.6K | 0.00% | 00.0% | Unchanged |
| Prudential Financial Inc | 57,800 | $42.8K | 0.00% | 00.0% | Unchanged |
| DCF Advisers, LLC | 69,871 | $51.7K | 0.04% | −41,752−37.4% | Reduced |
| Callan Capital, LLC | 103,688 | $76.7K | 0.01% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 125,500 | $92.9K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 172,387 | $127.6K | 0.00% | +13,610+8.6% | Added |
| Renaissance Technologies LLC | 293,291 | $217.0K | 0.00% | −98,940−25.2% | Reduced |
| Tang Capital Management LLC | 400,000 | $296.0K | 0.04% | 00.0% | Unchanged |
| Cota Capital Management, LLC | 562,278 | $416.1K | 0.21% | 00.0% | Unchanged |
| Vanguard Group Inc | 836,930 | $619.3K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 873,609 | $646.5K | 0.00% | −317,716−26.7% | Reduced |
| Franklin Resources Inc | 895,000 | $662.3K | 0.00% | 00.0% | Unchanged |
| Decheng Capital Management III (Cayman), LLC | 4,447,308 | $3.29M | 1.10% | 00.0% | Unchanged |
| Deutsche Bank AG | 0 | $0 | 0.00% | −348,061−100.0% | Sold out |
| US Bancorp | 0 | $0 | 0.00% | −494−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −25−100.0% | Sold out |